Amphastar Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Rancho Cucamonga, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Amphastar Pharmaceuticals, Inc. has filed 950 SEC EDGAR filings since 11 Feb 2005

SEC filing history

Showing 726-750 of 941 matching filings.

Per page
25
Current page
30
CT ORDER File 001-36509

CT ORDER filing

Filing date
26 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 Apr 2017
Reporting date
21 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36509

DEFA14A

Filing date
21 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36509

DEF 14A

Filing date
21 Apr 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Apr 2017
Reporting date
14 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Mar 2017
Reporting date
26 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Mar 2017
Reporting date
26 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Mar 2017
Reporting date
26 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Mar 2017
Reporting date
26 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Mar 2017
Reporting date
26 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-216700

S-8

Filing date
15 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36509

8-K

Filing date
13 Mar 2017
Reporting date
13 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88204

SC 13G AMENDMENT NO. 2

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88204

SC 13G filing

Filing date
09 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Jan 2017
Reporting date
03 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36509

8-K

Filing date
27 Dec 2016
Reporting date
27 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Dec 2016
Reporting date
15 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Dec 2016
Reporting date
05 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Dec 2016
Reporting date
01 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .